Business Description
TransMedics Group Inc
NAICS : 334510
SIC : 3845
ISIN : US89377M1099
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.7 | |||||
Equity-to-Asset | 0.25 | |||||
Debt-to-Equity | 2.72 | |||||
Debt-to-EBITDA | 17.05 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 4.55 | |||||
Beneish M-Score | 4.83 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 92.7 | |||||
3-Year EBITDA Growth Rate | 36.8 | |||||
3-Year EPS without NRI Growth Rate | 12.4 | |||||
3-Year FCF Growth Rate | -68.1 | |||||
3-Year Book Growth Rate | 3.2 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 40.8 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 11.43 | |||||
9-Day RSI | 22.66 | |||||
14-Day RSI | 30.25 | |||||
6-1 Month Momentum % | 70.52 | |||||
12-1 Month Momentum % | 252.11 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 9.37 | |||||
Quick Ratio | 8.48 | |||||
Cash Ratio | 6.68 | |||||
Days Inventory | 109.46 | |||||
Days Sales Outstanding | 68.14 | |||||
Days Payable | 28.4 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.3 | |||||
Shareholder Yield % | -8.52 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 60.71 | |||||
Operating Margin % | -0.22 | |||||
Net Margin % | 0.84 | |||||
FCF Margin % | -61.93 | |||||
ROE % | 1.98 | |||||
ROA % | 0.42 | |||||
ROIC % | -0.66 | |||||
3-Year ROIIC % | -0.22 | |||||
ROC (Joel Greenblatt) % | 6.85 | |||||
ROCE % | 2.39 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 2966.5 | |||||
Forward PE Ratio | 64.74 | |||||
PE Ratio without NRI | 2696.82 | |||||
PEG Ratio | 117.25 | |||||
PS Ratio | 11.24 | |||||
PB Ratio | 20.82 | |||||
Price-to-Tangible-Book | 22.45 | |||||
Price-to-Operating-Cash-Flow | 176.32 | |||||
EV-to-EBIT | 265.77 | |||||
EV-to-EBITDA | 139.45 | |||||
EV-to-Revenue | 11.78 | |||||
EV-to-Forward-Revenue | 6.88 | |||||
EV-to-FCF | -18.59 | |||||
Price-to-Graham-Number | 51.91 | |||||
Earnings Yield (Greenblatt) % | 0.38 | |||||
FCF Yield % | -5.43 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
TransMedics Group Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 331.973 | ||
EPS (TTM) (€) | 0.026 | ||
Beta | 0 | ||
Volatility % | 112.46 | ||
14-Day RSI | 30.25 | ||
14-Day ATR (€) | 3.099164 | ||
20-Day SMA (€) | 123.1 | ||
12-1 Month Momentum % | 252.11 | ||
52-Week Range (€) | 35.1 - 157.05 | ||
Shares Outstanding (Mil) | 33.31 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
TransMedics Group Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
TransMedics Group Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
TransMedics Group Inc Frequently Asked Questions
What is TransMedics Group Inc(STU:TMDX)'s stock price today?
When is next earnings date of TransMedics Group Inc(STU:TMDX)?
Does TransMedics Group Inc(STU:TMDX) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |